Tag Archives: Kazano

Heart Failure Risk with Onglyza, Similar Diabetes Drugs Lead to FDA Warnings

April 06, 2016 By: Austin Kirk

Onglyza and similar diabetes drugs may increase the risk of heart failure, according to an FDA warning that will lead to new label warnings being added to the drugs.
Januvia, Byetta Pancreatic Cancer Risk Review Launched by FDA

March 15, 2013 By: Austin Kirk

The FDA has launched an investigating into the possibility that diabetics may face an increased risk of pancreatitis and pancreatic cancer from an entire class of diabetes drugs, which includes…
Amid Actos Suits and Declined Sales, Takeda Pushes New Diabetes Drug

January 29, 2013 By: Irvin Jackson

As sales of the brand-name version of the diabetes drug Actos continue fall amid mounting injury lawsuits and recent generic competition, Takeda Pharmaceuticals has launched a trio of new drugs…

Philips CPAP Lawsuit Filing Deadlines May Be Approaching in Some Claims (Posted 5 days ago)

Lawyers are working to register and file Philips CPAP lawsuits, as the manufacturer may argue the June 14 anniversary of a massive recall triggered the start of the statute of limitations in certain states

More Than 60,000 Camp Lejeune Water Poisoning Claims Submitted by Injured Veterans, Family Members: Report (Posted 9 days ago)

A new report indicates the U.S. Navy is struggling to process tens of thousands of Camp Lejeune water poisoning claims due to a lack of resources.

Motion Filed to Centralize Bard Implanted Port Lawsuits in Federal Court System (Posted 9 days ago)

A group of plaintiffs have filed a motion with the U.S. JPML seeking consolidation of all Bard implanted port lawsuits before one judge for pretrial proceedings.

Tag Archives: Kazano

Heart Failure Risk with Onglyza, Similar Diabetes Drugs Lead to FDA Warnings

Januvia, Byetta Pancreatic Cancer Risk Review Launched by FDA

Amid Actos Suits and Declined Sales, Takeda Pushes New Diabetes Drug

More Top Stories

Review A Case